Tome Biosciences
Watertown
About Tome Biosciences
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $213.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2023)
- Website: tome.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/tome-biosciences-20636 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.